Primary Central Nervous System Effusion Plasmablastic Lymphoma In Immunocompromised Patient: A Rare Phenomenon

Singh, Brij Mohan Kumar and Belurkar, Sushma and Bisnu, Arijit and Shetty, Tanvi and Pavithra, P (2018) Primary Central Nervous System Effusion Plasmablastic Lymphoma In Immunocompromised Patient: A Rare Phenomenon. Asian Journal of Pharmaceutical and Clinical Research, 11 (8). pp. 6-7. ISSN 0974-2441

[img] PDF
5438 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (447kB) | Request a copy

Abstract

Primary effusion lymphoma (PEL) is an aggressive neoplasm with a high rate of fatality. PEL cells are known to have morphological diversities, which range from immunoblastic or plasmablastic to anaplastic. Most of these cases are described in immunocompromised as well as immunocompetent patients. Plasmablastic lymphoma remains a diagnostic challenge, especially when encountered with the presentation as PEL. In spite of therapeutic advances, PEL remains an aggressive disease with a high rate of fatality. We describe one case of this extremely rare neoplasm in an immunocompromised patient presenting in the form of primary central nervous system effusion plasmablastic lymphoma. To the best of our knowledge, this is the first case ever been reported in the literature.

Item Type: Article
Uncontrolled Keywords: Primary effusion lymphoma; Plasmablastic lymphoma; Papanicolaou smear; Flow cytometry
Subjects: Medicine > MMMC Manipal > Pathology
Medicine > KMC Manipal > Pathology
Depositing User: KMC Library
Date Deposited: 13 Feb 2019 04:16
Last Modified: 13 Feb 2019 04:16
URI: http://eprints.manipal.edu/id/eprint/153256

Actions (login required)

View Item View Item